發(fā)表論文、論著情況
1、Hongcai Li, Chao Wang, Tino Sanchez, Chunying Jiang, Nouri Neamati and Guisen Zhao. Amide-containing diketoacids as HIV-1 integrase inhibitors: Synthesis, structure-activity relationship analysis and biological activity. Bioorganic & Medicinal Chemistry. 2009, 17: 2913-2919.
2、Peng Wang, Chuan Liu, Tino Sanches, Yuan Zhong, Bo Liu, Junlong Xiong, Nouri Neamati , and Guisen Zhao . Design and Synthesis of Novel Nitrogen-containing Polyhydroxylated Aromatics as HIV-1 Integrase Inhibitors from Caffeic Acid Phenethyl Ester. Bioorganic & Medicinal Chemistry Letters. 2009, available online.
3、Guisen Zhao, Chao Wang, Chuan Liu and Hongxiang Lou. New Developments in Diketo- Containing Inhibitors of HIV-1 Integrase . Mini-Reviews in Medicinal Chemistry, 2007, 7(7):707-725.
4、Rui Wang, Chunmin Li, Dandan Song, Guisen Zhao, Linxiang Zhao, and Yongkui Jing. Ethacrynic Acid Butyl-Ester Induces Apoptosis in Leukemia Cells through a Hydrogen Peroxide–Mediated Pathway Independent of Glutathione S-Transferase P1-1 Inhibition. Cancer Res, 2007; 67(16):7856-7864.
5、Guisen Zhao and Xiaobing Wang. Advance in antitumor agents targeting glutathione- S-transferas. Current Medicinal Chemistry, 2006,13(12):1461-1471.
6、Guisen Zhao, Chuan Liu, Rui Wang, Dandan Song, Xiaobing wang, Hongxiang Lou and Yongkui Jing. The synthesis ofα, β-unsaturated carbonyl derivatives with the ability to inhibit both glutathione S-transferase P1-1 activity and the proliferation of leukemia cells. Bioorganic & Medicinal Chemistry, 2007, 15: 2701–2707
7、Guisen Zhao, Tao Yu, Rui Wang, et al. Synthesis and Structure-activity Relationship of Ethacrynic Acid Analogues on Glutathione-s-transferase P1-1 Activity Inhibition. Bioorganic & Medicinal Chemistry, 2005. 13:4056-4062 (SCI 2.185)
8、Yu-Wen Xu, Gui-Sen Zhao*, Cha-Gyun Shin, et al. Caffeoyl Naphthalene- sulfonamide Derivatives as HIV Integrase Inhibitors. Bioorganic & Medicinal Chemistry, 2003,11:3589-3593.(SCI 2.185)
王小兵,牛華英,趙桂森*。5-(N-取代氨基)磺?;?1-萘胺的合成?;瘜W(xué)試劑,2005,27(8):449-450
王小兵,趙桂森*。海洋抗癌活性物質(zhì)最新研究概況。藥學(xué)進展,2005,29(7):302-309
趙思太,臧恒昌,趙桂森*。美國FDA最新批準上市的治療AIDS藥物。中國新藥雜志,2005,14(3):373-374。
趙桂森*,臧恒昌,王小兵,等。咖啡酸衍生物的合成及其抑制HIV整合酶活性。中國藥物化學(xué)雜志,2005,15(2):70-75
趙桂森(編委)《藥物化學(xué)》科學(xué)技術(shù)文獻出版社,北京:2005.2.
王小兵,袁玉梅,趙桂森*。O6-甲基鳥嘌呤-DNA-甲基轉(zhuǎn)移酶與腫瘤。食品與藥品,2005,7(2):15-17。
高彥慧,趙桂森*,等。HPLC法測定米氮平的含量及其有關(guān)物質(zhì)。山東大學(xué)學(xué)報,2004,42(6):373-374
劉永久,趙桂森*,徐玉文。融合抑制劑的研究進展,藥學(xué)進展,2004,28(4):168-172
于韜,趙桂森*,臧恒昌,等. 腫瘤多藥耐藥逆轉(zhuǎn)劑研究進展,中國藥物化學(xué)雜志,2003,13(3):172-178
趙桂森(編者). 國家執(zhí)業(yè)藥師資格考試復(fù)習(xí)應(yīng)試全書,北京科學(xué)技術(shù)出版社,2003年6月
徐玉文,趙桂森*??拱滩∷幬镅芯窟M展,中國藥物化學(xué)雜志 2002,12(2):119-124
徐玉文,趙桂森*,劉永久。人免疫缺陷病毒整合酶抑制劑的研究現(xiàn)狀,藥學(xué)進展,2002,26(3):138-142
趙桂森,劉永久,徐玉文。1-去氧-D-核糖的合成,中國現(xiàn)代應(yīng)用藥學(xué),2002,19(1):47-48
趙桂森(編者). 眼科藥物的臨床應(yīng)用與研究,中國醫(yī)藥科技出版社,2002.1.
王維紅,趙桂森*,等。鹽酸索他洛爾片的含量測定及穩(wěn)定性研究,山東醫(yī)科大學(xué)學(xué)報,2001,39(3):215-217.
趙桂森,徐玉文。4(R)-(6-氨基-9-嘌呤基)2(R)-(羥甲基)四氫呋喃-3(R)醇的合成,中國藥物化學(xué)雜志,2001,11(3):138-141.
趙桂森, 袁玉梅, 劉偉,等. 索他洛爾的合成及其抗心律失?;钚?山東醫(yī)科大學(xué)學(xué)報,2001,39(1):35-37.
趙桂森,徐玉文。人免疫缺陷病毒酶抑制劑的研究進展,中國藥學(xué)會學(xué)術(shù)年會 2001,11:64.
趙桂森(副主編).《新藥設(shè)計與開發(fā)》科學(xué)出版社,北京:2001.2.
王唯紅,趙桂森*,等.反相高效液相色譜法測定鹽酸索他洛爾.色譜,2000,18(2):178-180.